980 related articles for article (PubMed ID: 12496057)
1. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development.
Wali RK; Stoiber D; Nguyen L; Hart J; Sitrin MD; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1316-21. PubMed ID: 12433708
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
4. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
5. Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+.
Momen MA; Monden Y; Houchi H; Umemoto A
J Med Invest; 2002 Feb; 49(1-2):67-73. PubMed ID: 11901763
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer.
Khare S; Cerda S; Wali RK; von Lintig FC; Tretiakova M; Joseph L; Stoiber D; Cohen G; Nimmagadda K; Hart J; Sitrin MD; Boss GR; Bissonnette M
Cancer Res; 2003 Jul; 63(13):3517-23. PubMed ID: 12839936
[TBL] [Abstract][Full Text] [Related]
7. 9trans,11trans conjugated linoleic acid inhibits the development of azoxymethane-induced colonic aberrant crypt foci in rats.
Yasui Y; Suzuki R; Kohno H; Miyamoto S; Beppu F; Hosokawa M; Miyashita K; Tanaka T
Nutr Cancer; 2007; 59(1):82-91. PubMed ID: 17927506
[TBL] [Abstract][Full Text] [Related]
8. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
Raju J; Patlolla JM; Swamy MV; Rao CV
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
[TBL] [Abstract][Full Text] [Related]
9. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
[TBL] [Abstract][Full Text] [Related]
10. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
Rao CV; Hirose Y; Indranie C; Reddy BS
Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis.
Tanaka T; Kojima T; Suzui M; Mori H
Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716
[TBL] [Abstract][Full Text] [Related]
12. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
[TBL] [Abstract][Full Text] [Related]
13. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
Janakiram NB; Steele VE; Rao CV
Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
[TBL] [Abstract][Full Text] [Related]
16. Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis.
Kwon Y; Magnuson BA
Scand J Gastroenterol; 2007 Jan; 42(1):72-80. PubMed ID: 17190766
[TBL] [Abstract][Full Text] [Related]
17. Varying effect of dietary lipids and azoxymethane on early stages of colon carcinogenesis: enumeration of aberrant crypt foci and proliferative indices.
Bird RP; Lafave LM
Cancer Detect Prev; 1995; 19(4):308-15. PubMed ID: 7553672
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats.
Janakiram NB; Mohammed A; Ravillah D; Choi CI; Zhang Y; Desai D; Amin S; Rao CV
Oncol Rep; 2013 Aug; 30(2):952-60. PubMed ID: 23708609
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.
Narisawa T; Fukaura Y; Terada K; Sekiguchi H
J Exp Clin Cancer Res; 1999 Jun; 18(2):259-66. PubMed ID: 10464717
[TBL] [Abstract][Full Text] [Related]
20. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]